Cite
UHPLC-HRMS data from non-targeted screening for biotransformation products of cytostatic drug imatinib.
MLA
Tkalec, Žiga, et al. “UHPLC-HRMS Data from Non-Targeted Screening for Biotransformation Products of Cytostatic Drug Imatinib.” Data in Brief, vol. 41, Feb. 2022, p. 107991. EBSCOhost, https://doi.org/10.1016/j.dib.2022.107991.
APA
Tkalec, Ž., Negreira, N., López de Alda, M., Barceló, D., & Kosjek, T. (2022). UHPLC-HRMS data from non-targeted screening for biotransformation products of cytostatic drug imatinib. Data in Brief, 41, 107991. https://doi.org/10.1016/j.dib.2022.107991
Chicago
Tkalec, Žiga, Noelia Negreira, Miren López de Alda, Damiá Barceló, and Tina Kosjek. 2022. “UHPLC-HRMS Data from Non-Targeted Screening for Biotransformation Products of Cytostatic Drug Imatinib.” Data in Brief 41 (February): 107991. doi:10.1016/j.dib.2022.107991.